Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial
- Status
- RECRUITING
- Phase
- PHASE2
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
- Status
- WITHDRAWN
- Phase
- PHASE4
A Lactation Study in Women Receiving Treatment With Ozanimod
- Status
- WITHDRAWN
- Phase
- PHASE4
A Study to Assess Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan
- Status
- COMPLETED
- Phase
- N/A
Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany
- Status
- RECRUITING
- Phase
- N/A